China Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,100,152,000 | $924 | $1,369 | $2,149 |
Gross Profit | 1,100,150,380 | -1,120 | -290 | -79 |
EBITDA | -1,085,257,000 | -648 | -179 | |
EBIT | -1,085,257,696 | -1,389 | -913 | |
Net Income | -1,117 | -1,438 | -955 | -1,232 |
Net Change In Cash | 1,100,152,000 | 924 | 1,369 | 2,149 |
Free Cash Flow | -723,701,314 | -100 | -585 | -26 |
Cash | 718,691,000 | 739 | 838 | 1,423 |
Basic Shares | 17,306 | 16,124 | 13,133 | 10,625 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,011 | $8,104 | $9,641 | $10,866 |
Gross Profit | -504 | -493 | 349 | 1,952 |
EBITDA | 8 | -837 | 230 | 106 |
EBIT | -2,745 | -3,538 | -2,857 | -2,572 |
Net Income | -3,078 | -10,221 | -3,941 | -3,160 |
Net Change In Cash | 7,011 | 8,104 | 9,641 | 10,866 |
Cost of Revenue | -227 | |||
Free Cash Flow | -711 | -811 | -687 | -909 |
Cash | 1,423 | 2,029 | 4,859 | 957 |
Basic Shares | 3,383 | 5,256 | 4,612 | 4,362 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.06 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.07 |
2023-12-31 | -$0.11 |
